ConductScience.org, home

Paper33468698

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.

Peng S and 9 others. mBio, 2021. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody. Papers, record 33468698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33468698

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
PubMed
Journal
mBio
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
4.67
iCite
Revised in PubMed
2024-07-19
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peng SShiwen
2Ferrall LLouise
3Gaillard SStephanie
4Wang CChenguang
5Chi WYWei-Yu
6Huang CHChuan-Hsiang
7Roden RBSRichard B Shttps://orcid.org/0000-0002-2506-0195
8Wu TCT-Chttps://orcid.org/0000-0003-1623-4584
9Chang YNYung-Nien
10Hung CFChien-Fuhttps://orcid.org/0000-0001-9170-7797

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Human papillomavirus 16Major topic
Human papillomavirus 18Major topic
Papillomavirus InfectionsMajor topic
Papillomavirus VaccinesMajor topic
Uterine Cervical NeoplasmsMajor topic
Vaccines, DNAMajor topic
Animals
Antibodies, Monoclonal
Bacterial Proteins
DNA-Binding Proteins
Female
HSP70 Heat-Shock Proteins
Humans
Immunization, Secondary
Mice
Mice, Inbred C57BL
Oncogene Proteins, Viral
Papillomavirus E7 Proteins
Programmed Cell Death 1 Receptor
Protein Engineering
Recombinant Fusion Proteins
Repressor Proteins
Survival Analysis
Vaccination
Vaccinia virus

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 CA098252NCI NIH HHSUnited StatesP50CA098252PubMed and NIHNIH RePORTER
R01 CA233486NCI NIH HHSUnited StatesR01CA233486PubMed and NIHNIH RePORTER
R01 CA237067NCI NIH HHSUnited StatesR01CA237067PubMedNIH RePORTER
R01 GM136711NIGMS NIH HHSUnited StatesR01GM136711PubMedNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00788164Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial NeoplasiaDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18794328Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.J Virol1996https://conductscience.org/library/papers/8794328PubMed
212883527CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.Gene Ther2003https://conductscience.org/library/papers/12883527PubMed
324812273Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors.Cancer Res2014https://conductscience.org/library/papers/24812273PubMed
411257391Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.Vaccine2001https://conductscience.org/library/papers/11257391PubMed
530350310Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.Int J Cancer2019https://conductscience.org/library/papers/30350310PubMed
630296681Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination.Virology2018https://conductscience.org/library/papers/30296681PubMed
710451482Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol1999https://conductscience.org/library/papers/10451482PubMed
816353149Definition of an HPV18/45 cross-reactive human T-cell epitope after DNA immunisation of HLA-A2/KB transgenic mice.Int J Cancer2006https://conductscience.org/library/papers/16353149PubMed
910523825Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.Oncogene1999https://conductscience.org/library/papers/10523825PubMed
108617242The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.EMBO J1996https://conductscience.org/library/papers/8617242PubMed
1132695664High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions.Front Oncol2020https://conductscience.org/library/papers/32695664PubMed
1219118066A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.Clin Cancer Res2009https://conductscience.org/library/papers/19118066PubMed
1310822298Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity.Gene Ther2000https://conductscience.org/library/papers/10822298PubMed
148208532Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.Oncogene1994https://conductscience.org/library/papers/8208532PubMed
1514985791Comparison of HPV DNA vaccines employing intracellular targeting strategies.Gene Ther2004https://conductscience.org/library/papers/14985791PubMed
1628368072Review of HPV-related diseases and cancers.New Microbiol2017https://conductscience.org/library/papers/28368072PubMed
1725752814Human papillomavirus molecular biology and disease association.Rev Med Virol2015https://conductscience.org/library/papers/25752814PubMed
1818781156DNA vaccines: ready for prime time?Nat Rev Genet2008https://conductscience.org/library/papers/18781156PubMed
1910201889Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells.J Immunol1999https://conductscience.org/library/papers/10201889PubMed
2026403783Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers.Mod Pathol2015https://conductscience.org/library/papers/26403783PubMed

See all 80 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42930118Integrated Microfluidic CRISPR-Based Diagnostic Device for Rapid Testing of HPVs.Biosensors (Basel)2026https://conductscience.org/library/papers/42930118PubMed
42883212Heterologous Antigen Regimen and Bicistronic DNA Vaccination Targeting HPV16 E5 and E7 Oncoproteins: Immunoinformatics and Preclinical Antitumor Efficacy.Molecules2026https://conductscience.org/library/papers/42883212PubMed
42643979A Cell-Penetrating Peptide and Signal Sequence Fusion DNA Vaccine Enhances CD8+ T Cell-Mediated Anti-Tumor Immunity Targeting HPV-16 Cervical Cancer Antigens.Obstet Gynecol Res2026https://conductscience.org/library/papers/42643979PubMed
42568545Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming.Front Immunol2026https://conductscience.org/library/papers/42568545PubMed
42523483Stepwise Enhancement of HPV16 E6/E7 mRNA Vaccine Efficacy Using HSV-1 gD Epitope Incorporation and Immune-Modulating Agents.Res Sq2026https://conductscience.org/library/papers/42523483PubMed
42519393Oncolytic virus-mediated remodeling of tumor microenvironment enhances efficacy of an HPV16 E6/E7 mRNA vaccine in an HPV-positive tumor.Mol Ther Oncol2026https://conductscience.org/library/papers/42519393PubMed
42449784Development of a Double-Antibody Sandwich ELISA for the Detection of HPV16 E6 Protein.Diagnostics (Basel)2026https://conductscience.org/library/papers/42449784PubMed
42400858A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in mice.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42400858PubMed
42125658Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study.Front Immunol2026https://conductscience.org/library/papers/42125658PubMed
42079630A novel mRNA-based therapeutic vaccine elicits robust anti-tumor immunity against HPV-associated malignancies.Front Immunol2026https://conductscience.org/library/papers/42079630PubMed
41776327The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer.NPJ Precis Oncol2026https://conductscience.org/library/papers/41776327PubMed
41084861Recombinant lactococcus lactis expressing HPV-16 E6E7 dual antigens for potential cervical cancer treatment enhances dendritic cell vaccines efficacy.Future Microbiol2025https://conductscience.org/library/papers/41084861PubMed
41012179Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer.Vaccines (Basel)2025https://conductscience.org/library/papers/41012179PubMed
40479650Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control.J Exp Med2025https://conductscience.org/library/papers/40479650PubMed
40336572Genetic adjuvants: A paradigm shift in vaccine development and immune modulation.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40336572PubMed
40316302Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy.J Immunother Cancer2025https://conductscience.org/library/papers/40316302PubMed
40283217Expression of 9-O-Acetylated Sialic Acid in HPV+ Oral Squamous Cell Carcinoma Cells.Life (Basel)2025https://conductscience.org/library/papers/40283217PubMed
40282913Evaluation of the Efficacy of Active Hexose Correlated Compound as an Adjuvant in Reducing Recurrence After Condyloma Cauterization.Medicina (Kaunas)2025https://conductscience.org/library/papers/40282913PubMed
40007779Unraveling HPV-associated cancer complexity: From molecular insights to innovative therapies.Heliyon2025https://conductscience.org/library/papers/40007779PubMed
39991713Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/39991713PubMed

See all 52 cited byDownload CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
EXOSC95393PubTator's text mininghttps://conductscience.org/library/genes/5393NCBI Gene
GAD22572PubTator's text mininghttps://conductscience.org/library/genes/2572NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
HSPA43308PubTator's text mininghttps://conductscience.org/library/genes/3308NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
LAMB422798PubTator's text mininghttps://conductscience.org/library/genes/22798NCBI Gene
MBL3P50639PubTator's text mininghttps://conductscience.org/library/genes/50639NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
RB15925PubTator's text mininghttps://conductscience.org/library/genes/5925NCBI Gene
SERPING1710PubTator's text mininghttps://conductscience.org/library/genes/710NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
VPS26C10311PubTator's text mininghttps://conductscience.org/library/genes/10311NCBI Gene
XAB256949PubTator's text mininghttps://conductscience.org/library/genes/56949NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
IMIQUIMODCHEMBL1282Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1282

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33468698

GET https://conductscience.org/api/papers/v1/33468698/references?page=2